NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 760 filers reported holding NOVARTIS A G in Q2 2013. The put-call ratio across all filers is 0.60 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $1,871,000 | +148.5% | 20,494 | +161.7% | 0.02% | +112.5% |
| Q1 2019 | $753,000 | +727.5% | 7,832 | +636.8% | 0.01% | +700.0% |
| Q4 2018 | $91,000 | +2175.0% | 1,063 | +1732.8% | 0.00% | – |
| Q2 2018 | $4,000 | -98.6% | 58 | -98.3% | 0.00% | -100.0% |
| Q3 2017 | $286,000 | +221.3% | 3,331 | +177.4% | 0.00% | +200.0% |
| Q1 2017 | $89,000 | -55.3% | 1,201 | -56.1% | 0.00% | -50.0% |
| Q4 2016 | $199,000 | -13.1% | 2,736 | -5.8% | 0.00% | 0.0% |
| Q3 2016 | $229,000 | -71.8% | 2,904 | -70.5% | 0.00% | -80.0% |
| Q2 2016 | $811,000 | +4670.6% | 9,831 | +4742.9% | 0.01% | – |
| Q1 2014 | $17,000 | -86.3% | 203 | -86.8% | 0.00% | -100.0% |
| Q4 2013 | $124,000 | -73.9% | 1,543 | -75.1% | 0.00% | -77.8% |
| Q3 2013 | $475,000 | +191.4% | 6,193 | +168.3% | 0.01% | +125.0% |
| Q2 2013 | $163,000 | – | 2,308 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |